Baicalin attenuates Alzheimer-like pathological changes and memory deficits induced by amyloid β1–42 protein
- 10 August 2014
- journal article
- Published by Springer Science and Business Media LLC in Metabolic Brain Disease
- Vol. 30 (2), 537-544
- https://doi.org/10.1007/s11011-014-9601-9
Abstract
Baicalin is one bioactive flavone with anti-inflammatory and neuroprotective activities. The neuroprotective effects of baicalin on pathological changes and behavioral deficits were explored in a mouse model of amyloid β (Aβ) 1–42 protein-induced Alzheimer’s disease (AD). Mice received a bilateral injection of Aβ1–42 protein into the hippocampus, then they were treated with baicalin (30, 50 and 100 mg/kg body weight, orally) or Tween 80. The therapeutic effects of baicalin were monitored by Morris water maze trial and probe test. Then mice were sacrificed for immunohistochemistry and western blot analysis. After a relatively short-term treatment of 14 days, 100 mg/kg of baicalin significantly ameliorated memory impairment in the Morris water maze test and probe test, and also attenuated glial cell activations and increase of TNF-α and IL-6 expressions induced by Aβ1–42 protein. These results suggest that baicalin ameliorated Aβ1–42 protein-related pathology and cognitive dysfunction via its anti-neuroinflammatory activity, and may be a potential candidate for the treatment of AD.Keywords
This publication has 46 references indexed in Scilit:
- Nanoemulsion improves the oral bioavailability of baicalin in rats: in vitro and in vivo evaluationInternational Journal of Nanomedicine, 2013
- Baicalin’s Therapeutic Time Window of Neuroprotection during Transient Focal Cerebral Ischemia and Its Antioxidative EffectsIn VitroandIn VivoEvidence-Based Complementary and Alternative Medicine, 2013
- A Review: Inflammatory Process in Alzheimer's Disease, Role of CytokinesThe Scientific World Journal, 2012
- Botanical Flavonoids on Coronary Heart DiseaseThe American Journal of Chinese Medicine, 2011
- Soluble βamyloid1‐42: a critical player in producing behavioural and biochemical changes evoking depressive‐related state?British Journal of Pharmacology, 2010
- Alzheimer's DiseaseThe New England Journal of Medicine, 2010
- Substrate-targeting γ-secretase modulatorsNature, 2008
- Pathways towards and away from Alzheimer's diseaseNature, 2004
- Mutant Presenilin 2 Transgenic MiceOnline Journal of Public Health Informatics, 2000
- The carboxy terminus of the .beta. amyloid protein is critical for the seeding of amyloid formation: Implications for the pathogenesis of Alzheimer's diseaseBiochemistry, 1993